6. Metabolomics and Lipidomics Research Accelerated by Trapped Ion Mass Spectrometry
How can trapped ion mass spectrometry (TIMS) support advances in cellular biochemistry, and what could this mean for personalised medicine moving forwards?
10. Advances in Acousto-Optic Multiphoton Laser Scanning Microscopy
What benefits to laboratories can be caused by new developments in visualisation technology, and how can they overcome issues associated with analysis?
14. SLIM-Based High-Resolution Ion Mobility to Interrogate Glycopeptide Heterogeneity
New improvements in High Resolution Ion Mobility (HRIM) could impact the separation ability, throughput and reproducibility, and understanding of glycoprotein structures – what might this mean for researchers?
20. The Importance of Temperature Control in Pharmaceutical Analysis
As technology within the analysis sphere continues to evolve, how can temperature control be better implemented during drug R&D and why is it becoming increasingly important?
Discovery & Development
22. People, Pipelines, Projections: What Can Be Done To Help Emerging Therapeutics Get to Market Efficiently?
The potential answers to this question are numerous.
asked representatives from across the pharma sector for their opinions, with answers including tools, assays, and improved collaboration.
26. Is the UK Healthcare Industry Ready to Harness the Potential of Big Data?
Has the data collection that began during the COVID-19 pandemic across the pharma industry continued?
30. Human-Centred Design: From Inception to Integration
discusses the digital innovations that are leading humancentred design with Dr Chris Vincent at PDD, and whether technologies like XR can be beneficial to the research process.
34. Providing Support Throughout The Patient Journey
Concierge support services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. How best can they be implemented?
37. A Novel Approach to Inhalation Therapy
Can advances made in nicotine delivery, such as in e-cigarette devices, be applied to the delivery of other active substances?
42. Three Lessons Pharma Can Learn From Manufacturing to Become a Leader in Automation
Pharmaceutical companies face plenty of challenges throughout the manufacturing cycle. Automation can be the key to bringing the industry to the forefront of this exciting field.
46. AI, 3D Reconstruction, and Robotics in Clinical Phlebotomy
speaks to Toon Overbeeke of Vitestro about the potential benefits of using robots in clinics to draw blood from patients. With a shortage of clinical staff all over Europe, Toon believes robotics is the way forward regarding individual clinical patient care.
48. The Future of Digitalisation in the Lab
Mikael Hagstroem, CEO of LabVantage Solutions, tells
about the ongoing potential for laboratories of adopting AI and machine learning (ML), and the benefits that this could bring across the development timeline.
5. Editorial Desk
This issue of
calls attention to the potential of new opportunities, as in addition to the cutting-edge advancements across the pharma sector being discussed in the magazine, we also return with a brand new website, and lots of content to fill it.
50. Events Index
This theme of new opportunities continues into the new year, with several exciting events taking place throughout the start of 2023.
Index of Advertisers
Global Pharmaceutical Webinars
International Clinical Researcher of the Year Awards
Natoli Engineering Company Inc.
PMGroup Worldwide Ltd
GROUP MANAGING EDITOR
EDITORIAL AND PRODUCTION ASSISTANT
SFC – Shutterstock.com
by IPT Online
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
Hardings Print Solutions
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables, Timworth Green,
Tel: 01580 883841
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2022 Samedan Ltd